1.State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China
2.Biomedical Pioneering Innovation Center, Peking University, Beijing, 100871, China
3.School of Life Sciences, Peking University, Beijing, 100871, China
4.School of Instrument Science and Optoelectronics Engineering, Beijing Information Science & Technology University, Beijing, 100192, China
5.Biomedical Engineering Department, Peking University, Beijing, 100081, China
6.Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, 100142, China
Zhu X. et al. Reply to Comment on "In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells". Light: Science & Applications, 10, 2000-2001 (2021).
DOI:
Zhu X. et al. Reply to Comment on "In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells". Light: Science & Applications, 10, 2000-2001 (2021). DOI: 10.1038/s41377-021-00625-3.
Reply to Comment on "In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells"
Zhu, X. et al. In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells.Light.: Sci. Appl.10, 1–10 (2021)..
Williams, A. L., Fitzgerald, J. E., Ivich, F., Sontag, E. D.&Niedre, M. Short-term circulating tumor cell dynamics in mouse xenograft models and implications for liquid biopsy.Front. Oncol.10, 2447 (2020)..
Juratli, M. A. et al. Dynamic fluctuation of circulating tumor cells during cancer progression.Cancers6, 128–142 (2014)..
Wagner, J., Wickman, E., DeRenzo, C.&Gottschalk, S. CAR T-cell therapy for solid tumors: bright future or dark reality?Mol. Ther.28, 2320–2339 (2020)..
Rafiq, S., Hackett, C. S.&Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy.Nat. Rev. Clin. Oncol.17, 147–167 (2020)..
He, W. et al. Circadian expression of migratory factors establishes lineage-specific signatures that guide the homing of leukocyte subsets to tissues.Immunity49, 1175–1190 (2018). e1177..
Méndez-Ferrer, S., Lucas, D., Battista, M.&Frenette, P. S. Haematopoietic stem cell release is regulated by circadian oscillations.Nature452, 442–447 (2008)..
Scheiermann, C. et al. Adrenergic nerves govern circadian leukocyte recruitment to tissues.Immunity37, 290–301 (2012)..
Noonan, K.&Borrello, I. The immune microenvironment of myeloma.Cancer Microenviron.4, 313–323 (2011)..
Roccaro, A. M. et al. CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal-transition-like transcriptional activation.Cell Rep.12, 622–635 (2015)..
Vandyke, K. et al. HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1.Cancer Res.77, 5452–5463 (2017)..
Paiva, B. et al. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile.Blood122, 3591–3598 (2013)..
Fan, Z. -C. et al. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.Cancer Res.72, 2683–2691 (2012)..
Netterberg, I. et al. Comparing circulating tumor cell counts with dynamic tumor size changes as predictor of overall survival: a quantitative modeling framework.Clin. Cancer Res.26, 4892–4900 (2020)..
Kaifi, J. T. et al. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.Cancer Biol. Ther.16, 690–698 (2015)..